Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $311.5700 (0.13%) ($309.6600 - $315.7100) on Mon. Jul. 7, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.42% (three month average) | | RSI | 49 | | Latest Price | $311.5700(0.13%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 2.3% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | | Factors Impacting REGN price | REGN will decline at least -1.21% in a week (0% probabilities).
VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.21% (StdDev 2.42%) | | Hourly BBV | 0 () | | Intraday Trend | -0.2% | | | | | |
|
| 5 Day Moving Average | $303.43(2.68%) | | 10 Day Moving Average | $292.14(6.65%) | | 20 Day Moving Average | $297.86(4.6%) | | To recent high | -0.7% | | To recent low | 12.4% | | Market Cap | $33.035b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |